Bruce A Goldsmith Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bruce A Goldsmith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bruce A Goldsmith. Bruce A Goldsmith is SVP, Corporate Development in ALLOS THERAPEUTICS INC ($ALTH) and VP, Corporate Development in ALLOS THERAPEUTICS INC ($ALTH) and CEO and President in Passage BIO, Inc. ($PASG).
Latest Insider Trading Transactions of Bruce A Goldsmith
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | PASG | Passage BIO, Inc. | Goldsmith Bruce A | CEO and President | Option Exercise | A | 21.85 | 262,000 | 5,724,700 | 262,000 | |
| Sep 05 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | U | 1.82 | 346,933 | 631,418 | 0 | 346.9 K to 0 (-100.00 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.50 | 4,473 | 6,690 | 346,933 | 351.4 K to 346.9 K (-1.27 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.52 | 4,505 | 6,869 | 351,406 | 355.9 K to 351.4 K (-1.27 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Grant | A | 0.00 | 179,727 | 0 | 355,911 | 176.2 K to 355.9 K (+102.01 %) |
| Feb 27 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.54 | 575 | 888 | 176,184 | 176.8 K to 176.2 K (-0.33 %) |
| Feb 27 2012 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.58 | 2,500 | 3,958 | 176,759 | 179.3 K to 176.8 K (-1.39 %) |
| Nov 17 2011 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.43 | 300 | 430 | 179,259 | 179.6 K to 179.3 K (-0.17 %) |
| Nov 17 2011 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | SVP, Corporate Deve ... | Sell | S | 1.44 | 12,465 | 18,008 | 179,559 | 192 K to 179.6 K (-6.49 %) |
| Mar 02 2011 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | VP, Corporate Devel ... | Grant | A | 0.00 | 67,298 | 0 | 192,024 | 124.7 K to 192 K (+53.96 %) |
| Feb 25 2011 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | VP, Corporate Devel ... | Sell | S | 3.12 | 507 | 1,583 | 124,726 | 125.2 K to 124.7 K (-0.40 %) |
| Feb 25 2011 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | VP, Corporate Devel ... | Sell | S | 3.25 | 2,250 | 7,313 | 125,233 | 127.5 K to 125.2 K (-1.76 %) |
| Oct 22 2010 | ALTH | ALLOS THERAPEUTICS ... | Goldsmith Bruce A | VP, Corporate Devel ... | Grant | A | 0.00 | 100,671 | 0 | 127,483 | 26.8 K to 127.5 K (+375.47 %) |
Page: 1